Related content

National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening - on the down side of a prostate specific antigen induced peak in incidence-data from the Utah Cancer Registry

By Farkas A.   Schneider D.   Perrotti M.   Cummings K.B.   Ward W.S.  

Urology, Vol. 52, Iss. 3, 1998-09 ,pp. : 444-448

Elsevier

Access to resources Recommend Favorite

Costs and effects of prostate cancer screening in Sweden

By Sennfält Karin   Sandblom Gabriel   Carlsson Per   Varenhorst Eberhard  

Scandinavian Journal of Urology and Nephrology, Vol. 38, Iss. 4, 2004-09 ,pp. : 291-298

Informa Healthcare

Access to resources Recommend Favorite

United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region

By McNaughton Collins M.   Barry M.J.   Zietman A.   Albertsen P.C.   Talcott J.A.   Walker Corkery E.   Elliott D.B.   Fowler F.J.  

Urology, Vol. 60, Iss. 4, 2002-10 ,pp. : 628-633

Elsevier

Access to resources Recommend Favorite

Impact of prostate-specific antigen screening on prostate cancer

By Zincke H.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 783-783

Elsevier

Access to resources Recommend Favorite

Epidemiology of prostate cancer: molecular and environmental clues

By Pienta K.J.   Goodson J.A.   Esper P.S.  

Urology, Vol. 48, Iss. 5, 1996-11 ,pp. : 676-683

Elsevier

Access to resources Recommend Favorite